Cinobufagin

Cinobufagin

CAT N°: 19844
Price:

From 172.00 146.20

Cinobufagin is a cardiotonic steroid that has been found in the skin of toads of genus Bufo and has diverse biological activities.{48257,48258,48259,48260} It inhibits Na+/K+-ATPase activity in guinea pig heart ventricular muscle homogenates by 45% when used at a concentration of 0.3 ?M.{48257} Cinobufagin is cytotoxic to HCT116 colorectal cancer cells in vitro with IC50 values of less than 50 ng/ml at 48- and 72-hour time points and induces apoptosis in a concentration-dependent manner.{48258} In vivo, cinobufagin (10 mg/kg) reduces tumor growth in an HCT116 mouse xenograft model. Cinobufagin (1 ?g/ml) inhibits LPS-induced expression of MHC class II, CD80, and CD86 and release of IL-6, IL-8, TNF-?, and IL-10 in human monocyte-derived dendritic cells.{48259} It also increases expression of the antimicrobial peptides hBD2 and hBD3 in dendritic cells. Cinobufagin exhibits dose-dependent antinociceptive effects in the hot-plate, acetic acid writhing, and formalin tests in mice.{48260}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (5?)-16?-(acetyloxy)-14,15?-epoxy-3?-hydroxy-bufa-20,22-dienolide
  • Correlated keywords
    • 1476-69-3 25875-35-8 HCT 116 lipopolysaccharide CD 80 86 interleukin IL6 IL8 TNF? IL10 tumor necrosis factor h BD2 BD3 BD 2 3 anti-nociceptive microbial Cinobufagenin Cinobufagine NSC90325 Cinobufogenin
  • Product Overview:
    Cinobufagin is a cardiotonic steroid that has been found in the skin of toads of genus Bufo and has diverse biological activities.{48257,48258,48259,48260} It inhibits Na+/K+-ATPase activity in guinea pig heart ventricular muscle homogenates by 45% when used at a concentration of 0.3 ?M.{48257} Cinobufagin is cytotoxic to HCT116 colorectal cancer cells in vitro with IC50 values of less than 50 ng/ml at 48- and 72-hour time points and induces apoptosis in a concentration-dependent manner.{48258} In vivo, cinobufagin (10 mg/kg) reduces tumor growth in an HCT116 mouse xenograft model. Cinobufagin (1 ?g/ml) inhibits LPS-induced expression of MHC class II, CD80, and CD86 and release of IL-6, IL-8, TNF-?, and IL-10 in human monocyte-derived dendritic cells.{48259} It also increases expression of the antimicrobial peptides hBD2 and hBD3 in dendritic cells. Cinobufagin exhibits dose-dependent antinociceptive effects in the hot-plate, acetic acid writhing, and formalin tests in mice.{48260}

We also advise you